Results 1-10 of approx. 274

Ahead Of The Bell: Endo Downgraded On Drug Delays

By The Associated Press 12/07/09

Endo Pharma downgraded as analyst expects more spending due to delayed approval for drugs. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10639661/1/ahead-of-the-bell-endo-downgraded-on-drug-delays.html

Endo Pharma to Buy Indevus for $370M

By TSC Staff 01/05/09

Endo will acquire Indevus for $370 million, or $4.50 per share.. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10456138/1/endo-pharma-to-buy-indevus-for-370m.html

Premarket Roundup: Brocade, Endo Pharma

By The Associated Press 12/07/09

Premarket roundup: Brocade gains as analyst boosts rating, Endo downgraded on FDA delays. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10639777/1/premarket-roundup-brocade-endo-pharma.html

Endo Pharmaceuticals Holdings Incorporated (ENDP) Stock Quote ...

Get the latest ENDP - Endo Pharmaceuticals Holdings Incorporated stock market performance data and financial news.

http://www.thestreet.com/quote/ENDP.html

Endocare Corporation (ENDO) Stock Quote

Get the latest ENDO - Endocare Corporation stock market performance data and financial news.

http://www.thestreet.com/quote/ENDO.html

FDA Extends Review Of Endo Drug By 3 Months

By The Associated Press 09/02/09

Endo Pharma says FDA extends review of testosterone injection to Dec. 2, from Sept. 2. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10593909/1/fda-extends-review-of-endo-drug-by-3-months.html

Endo Pharmaceuticals Provides Regulatory Update On AVEED(TM) ...

By PR Newswire 12/03/09

. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10637657/1/endo-pharmaceuticals-provides-regulatory-update-on-aveedtm-testosterone-undecanoate-injection.html

Endo 3Q Profit Falls On Indevus Buyout Costs

By The Associated Press 10/29/09

Endo Pharmaceuticals' 3rd-quarter profit dips on buyout costs; pain drugs drive revenue. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10618699/1/endo-3q-profit-falls-on-indevus-buyout-costs.html

Endo Says FDA Accepts Application For Nebido

By The Associated Press 03/12/09

Endo and Indevus say FDA aims to finish review of testosterone replacement Nebido by Sept. 2. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10471287/1/endo-says-fda-accepts-application-for-nebido.html

Endo Buys Testosterone Product For Up To $210M

By The Associated Press 08/26/09

Endo Pharma says it will pay up to $210M for ProStrakan's testosterone replacement Fortesta. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10590702/1/endo-buys-testosterone-product-for-up-to-210m.html

More From TheStreet

Latest Headlines

Brokerage Partners

TheStreet Premium Services

All Services